Effects of Baduanjin Compared to Brisk Walking on Postural Stability and Functional Outcomes in Early to Mid-Stage Parkinson's Disease: A Randomized Controlled Study - Report - MDSpire
Advertisement
Effects of Baduanjin Compared to Brisk Walking on Postural Stability and Functional Outcomes in Early to Mid-Stage Parkinson's Disease: A Randomized Controlled Study
Clinical Report: Effects of Baduanjin Compared to Brisk Walking on Postural Stability
Overview
This study demonstrates that Baduanjin offers superior improvements in motor symptoms and cognitive function compared to brisk walking in early to mid-stage Parkinson's disease patients, as measured by specific scales. Notably, Baduanjin also significantly reduces anxiety and depression levels.
Background
Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by motor and non-motor symptoms, including postural instability, which significantly impacts patients' quality of life. Current treatments primarily focus on pharmacological interventions, which may have limited efficacy for axial symptoms. Non-pharmacological approaches, such as Baduanjin, are increasingly explored as complementary therapies to enhance rehabilitation outcomes.
Data Highlights
Outcome Measure
Baduanjin Group
Brisk Walking Group
P-value
MDS-UPDRS-III
Improved
No significant change
< 0.05
Axial Subscale (6 weeks)
Improved
No significant change
0.038
Anxiety (HAMA at 12 weeks)
Reduced
No significant change
0.014
Cognition (MoCA at 6 weeks)
Improved
No significant change
0.015
Depression (HAMD)
Improved
No significant change
0.015
Key Findings
Baduanjin significantly improved motor symptoms as measured by MDS-UPDRS-III compared to brisk walking, with a percentage improvement of X%.
Improvements in the axial subscale were noted at 6 weeks for the Baduanjin group.
Baduanjin reduced anxiety levels significantly at 12 weeks.
Cognitive function improved in the Baduanjin group at 6 weeks.
Depression levels improved only in the Baduanjin group.
Both groups showed improvements in sleep quality and overall quality of life.
Clinical Implications
The findings suggest that Baduanjin may serve as an effective non-pharmacological intervention for improving motor and cognitive functions in patients with early to mid-stage Parkinson's disease. Clinicians may consider incorporating Baduanjin into rehabilitation programs, particularly for those experiencing anxiety and depression, by providing structured sessions and monitoring progress.
Conclusion
Baduanjin training presents a promising alternative to conventional brisk walking, offering significant benefits in managing motor symptoms and enhancing overall well-being in Parkinson's disease patients. Its integration into treatment plans may improve patient quality of life, but further research is needed to validate these findings.
